Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension

Hélène Bouvaist, Frédéric Thony, Marie Jondot, Boubou Camara, Xavier Jais, Christophe Pison
European Respiratory Review 2014 23: 393-395; DOI: 10.1183/09059180.00000514
Hélène Bouvaist
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hbouvaist@chu-grenoble.fr
Frédéric Thony
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Jondot
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boubou Camara
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Jais
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Pison
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
1Clinique Universitaire de Cardiologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 2Université Joseph Fourier, Grenoble, France. 3Clinique de Radiologie et Imagerie Médicale, Pôle Imagerie, CHU Grenoble, Grenoble, France. 4Clinique Universitaire de Pneumologie, Pôle Thorax, CHU Grenoble, Grenoble, France. 5Université Paris-Sud, Le Kremlin-Bicêtre, France. 6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. 7Inserm999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France. 8Inserm1055, Saint Martin d’Hères, France. 9European Institute for Systems Biology and Medicine, EISBM, Lyon, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

We report the first French case of percutaneous balloon pulmonary angioplasty (BPA) in a 78-year-old patient with chronic thromboembolic pulmonary hypertension (CTEPH). The patient had a history of acute pulmonary embolism in 2004 with recurrence in 2011. At the end of 2012, he complained of persistent dyspnoea and CTEPH was diagnosed on lung radionuclide perfusion scan, contrast chest computed tomography and right heart catheterisation. At the first evaluation, he was in New York Heart Association (NYHA) functional class III and his 6-min walk distance (6MWD) was 470 m. Mean pulmonary artery pressure (mPAP) was 45 mmHg, cardiac index 1.8 L·min−1·m−2 and pulmonary vascular resistance (PVR) 8 Wood units. He had used warfarin for 2 years, and combination therapy with bosentan and tadalafil was started (1 year before angioplasty) [1, 2]. Conventional pulmonary angiography showed that the main lesions were located in segmental pulmonary arteries of the lower lobes (fig. 1c). Webs, splits and occlusion were identified in A6, A8, A9 and A10 pulmonary arterial branches on the right lung, and A8, A9 and A10 on the left lung (fig. 1a).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

a) Segmentation of pulmonary arteries according to Cabrol. b) Table summarising the inflation pressure and size of balloons used for each treated segment. d) Visualisation of webs and splits with optical coherence tomography (OCT) before percutaneous angioplasty. Conventional pulmonary angiography of A8 segmental branch (left lung, lateral view) c) before and e) after balloon pulmonary angioplasty. Arrow indicates OCT cross section.

Pulmonary endarterectomy (PEA) was considered as feasible but at high risk given the age and the haemodynamic status of the patient [3, 4]. In addition, the patient declined surgical treatment. Therefore, percutaneous BPA was proposed for the treatment of this CTEPH as it has been promoted by Japanese groups [5, 6] and recently by a Norwegian group [7]. Renal function was normal. This protocol was approved by our institutional review board and ethics committee (Comité de Protection des Personnes SudEst V, Grenoble, France). The patient gave informed consent. He was hospitalised the day before the procedure. We maintained warfarin to achieve an international normalised ratio (INR) of 2.0. The procedure was conducted under local anaesthesia, through the right femoral vein. A 6F guide catheter (Judkins Right Launcher; Medtronic, Minneapolis, MN, USA) was used for each procedure (right pulmonary artery first and left pulmonary artery 8 days after). A 0.014 hydrophilic wire (Pilot 50; Abbott Vascular, Santa Clara, CA, USA) was inserted through target lesions (fig. 1c). We injected 50 U·kg−1 of unfractionated heparin intravenously at the beginning of the procedure. Then, heparin was given at a dose of 1000 U every hour until the end of the procedure.

BPA was performed with a 2×20-mm coronary balloon inflated in each target lesion, followed by coronary or renal balloons that were sized to be 80% of the vessel diameter (fig. 1b), as measured by optical coherence tomography (OCT) (fig. 1d). BPA of three segmental branches of the right lower lobe was conducted. Additional BPA of three segmental branches of the left lower lobe was performed 1 week later. The objective for each target vessel was to obtain an angiographic pulmonary flow grade 3 (fig. 1e) [8]. Each procedure required 350 mL of contrast agents. The cumulative radiation dose was 282 Gy·cm−2. At the end of the second procedure, mPAP was 29 mmHg, cardiac index was 2.5 L·min−1·m−2 and PVR was 4 Wood units.

The patient developed moderate haemoptysis due to reperfusion pulmonary injury 1 h after each procedure, which resolved spontaneously. No sign of arterial rupture or wire injury was visualised on the final angiographic assessment. Vasa vasorum rupture or alveolar flooding reperfusion may arise. This complication seems to be frequent, up to 50% in recent published series. The patient was hospitalised in the intensive care unit for 48 h and was discharged from the hospital on the fifth day after each procedure. Maintenance of warfarin, to bring the INR to 2, was our choice to limit haemorrhagic and thrombotic risk around angioplasty, and avoid post-procedure discharge delay; working under heparin could be a safeguard against bleeding during angioplasty.

The specific pulmonary hypertension therapy was also maintained. 3 months after the last procedure, his functional status was improved (NYHA functional class II), 6MWD was stable at 478 m, mPAP was 35 mmHg, cardiac index 2.5 L·min−1·m−2 and PVR 4 Wood units.

Balloon pulmonary angioplasty seems to be a feasible and efficient technique for the treatment of CTEPH in patients with operable form but unacceptable risk for PEA. With OCT monitoring, BPA for CTEPH lesions seems to be safer [6]. The technique needs to be standardised to avoid haemorrhagic, renal and radiation risks, and to ensure reproducibility.

Multicentre studies are required to define indications, confirm efficacy and to establish long-term results. Pooling of skills of the interventional cardiologists, chest physicians specialised in pulmonary hypertension and representative surgical centres for PEA will allow optimisation of the technique and determine its place in the management of CTEPH patients [9, 10].

Footnotes

  • Support Statement: This study was supported by a grant from CHU Grenoble (grant AO 2013DRC1324).

  • Provenance: Submitted article, peer reviewed.

  • Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

  • Received January 18, 2014.
  • Accepted February 13, 2014.
  • ©ERS 2014

ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Jais X,
    2. D’Armini AM,
    3. Jansa P,
    4. et al
    . Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52: 2127–2134.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Pepke-Zaba J,
    2. Jansa P,
    3. Kim NH,
    4. et al
    . Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J 2013; 41: 985–990.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Kim NH,
    2. Delcroix M,
    3. Jenkins DP,
    4. et al
    . Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl., D92–D99.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Jenkins DP,
    2. Madani M,
    3. Mayer E,
    4. et al
    . Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 2013; 41: 735–742.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Mizoguchi H,
    2. Ogawa A,
    3. Munemasa M,
    4. et al
    . Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 2012; 5: 748–755.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Sugimura K,
    2. Fukumoto Y,
    3. Satoh K,
    4. et al
    . Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–488.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Andreassen AK,
    2. Ragnarsson A,
    3. Gude E,
    4. et al
    . Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 2013; 99: 1415–1420.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Inami T,
    2. Kataoka M,
    3. Shimura N,
    4. et al
    . Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv 2013; 6: 725–736.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Jenkins D,
    2. Mayer E,
    3. Screaton N,
    4. et al
    . State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev 2012; 21: 32–39.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Lang IM,
    2. Pesavento R,
    3. Bonderman D,
    4. et al
    . Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013; 41: 462–468.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 23 Issue 133 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Hélène Bouvaist, Frédéric Thony, Marie Jondot, Boubou Camara, Xavier Jais, Christophe Pison
European Respiratory Review Sep 2014, 23 (133) 393-395; DOI: 10.1183/09059180.00000514

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Hélène Bouvaist, Frédéric Thony, Marie Jondot, Boubou Camara, Xavier Jais, Christophe Pison
European Respiratory Review Sep 2014, 23 (133) 393-395; DOI: 10.1183/09059180.00000514
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Hypoxaemia during pregnancy
  • Pulmonary hypertension and Whipple disease
Show more Letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society